European Commission authorises fourth safe and effective vaccine against COVID-19

Published on March 10, 2021

European Commission Press release Brussels, 11 Mar 2021 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the fourth COVID-19 vaccine authorised in the EU.

Other news

ECHO Daily Map of 10 March 2021

March 10, 2021
Coronavirus vaccine uptake in EU Member States and UCPM Participating States

The EU SME Strategy one year on: Challenges and Opportunities

March 11, 2021
The EU SME Strategy, published exactly one year ago by the European Commission aimed at helping small businesses leading the twin transition, reducing regulatory burdens and red tape, supporting market access and entrepreneurship, and improving access to financing. However, the COVID-19 pandemic is threatening the viability of European SMEs due to serious disruptions of global supply chains, trans